TGen Drug Development recognized for economic development of Arizona biosciences
(The Translational Genomics Research Institute) TGen Drug Development won a Fast Lane award from the Arizona BioIndustry Association for promoting the economic development of Arizona biosciences. TD2, a subsidiary of the Translational Genomics Research Institute, provides world-class clinical and regulatory expertise to biopharmaceutical companies using cutting-edge technology to minimize the risks in cancer drug development. TD2 works to shorten the development cycles for anti-cancer agents and improve their success rates.
